Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Zilli T, Dirix P, Heikkilä R, Liefhooghe N, Siva S, Gomez-Iturriaga A, Everaerts W, Otte F, Shelan M, Mercier C, Achard V, Thon K, Stellamans K, Moon D, Conde-Moreno A, Papachristofilou A, Scorsetti M, Gückenberger M, Ameye F, Zapatero A, Van De Voorde L, López Campos F, Couñago F, Jaccard M, Spiessens A, Semac I, Vanhoutte F, Goetghebeur E, Reynders D, Ost P. Zilli T, et al. Among authors: ost p. Eur Urol Focus. 2021 Mar;7(2):241-244. doi: 10.1016/j.euf.2020.12.010. Epub 2020 Dec 29. Eur Urol Focus. 2021. PMID: 33386290 Free article. Clinical Trial.
Developments in external beam radiotherapy for prostate cancer.
Lumen N, Ost P, Van Praet C, De Meerleer G, Villeirs G, Fonteyne V. Lumen N, et al. Among authors: ost p. Urology. 2013 Jul;82(1):5-10. doi: 10.1016/j.urology.2013.03.043. Epub 2013 May 21. Urology. 2013. PMID: 23706252 Free article. Review.
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P. Sassowsky M, et al. Among authors: ost p. Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):534-41. doi: 10.1016/j.ijrobp.2013.06.2053. Epub 2013 Aug 22. Int J Radiat Oncol Biol Phys. 2013. PMID: 23972722 Clinical Trial.
Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058-66.
Ost P, Briganti A, Giannarini G; Prostate Cancer Working Group of the Young Academic Urologist Working Party of the European Association of Urology. Ost P, et al. Eur Urol. 2014 Jun;65(6):e97-8. doi: 10.1016/j.eururo.2013.12.009. Epub 2013 Dec 17. Eur Urol. 2014. PMID: 24365126 No abstract available.
The oncologic role of local treatment in primary metastatic prostate cancer.
Ghadjar P, Briganti A, De Visschere PJ, Fütterer JJ, Giannarini G, Isbarn H, Ost P, Sooriakumaran P, Surcel CI, van den Bergh RC, van Oort IM, Yossepowitch O, Ploussard G. Ghadjar P, et al. Among authors: ost p. World J Urol. 2015 Jun;33(6):755-61. doi: 10.1007/s00345-014-1347-9. Epub 2014 Jul 5. World J Urol. 2015. PMID: 24997127 Review.
Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial.
Decaestecker K, De Meerleer G, Ameye F, Fonteyne V, Lambert B, Joniau S, Delrue L, Billiet I, Duthoy W, Junius S, Huysse W, Lumen N, Ost P. Decaestecker K, et al. Among authors: ost p. BMC Cancer. 2014 Sep 15;14:671. doi: 10.1186/1471-2407-14-671. BMC Cancer. 2014. PMID: 25223986 Free PMC article. Clinical Trial.
303 results